000 01318 a2200361 4500
005 20250518095549.0
264 0 _c20210618
008 202106s 0 0 eng d
022 _a1549-490X
024 7 _a10.1634/theoncologist.2019-0528
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVerschoor, Arie Jan
245 0 0 _aSingle-Center Experience with Ifosfamide Monotherapy as Second-Line Treatment of Recurrent/Metastatic Osteosarcoma.
_h[electronic resource]
260 _bThe oncologist
_c04 2020
300 _ae716-e721 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
650 0 4 _aBone Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aIfosfamide
_xtherapeutic use
650 0 4 _aNeoplasm Recurrence, Local
_xdrug therapy
650 0 4 _aOsteosarcoma
_xdrug therapy
650 0 4 _aRetrospective Studies
650 0 4 _aTreatment Outcome
700 1 _aSpeetjens, Frank M
700 1 _aDijkstra, P D Sander
700 1 _aFiocco, Marta
700 1 _avan de Sande, Michiel A J
700 1 _aBovée, Judith V M G
700 1 _aGelderblom, Hans
773 0 _tThe oncologist
_gvol. 25
_gno. 4
_gp. e716-e721
856 4 0 _uhttps://doi.org/10.1634/theoncologist.2019-0528
_zAvailable from publisher's website
999 _c30864366
_d30864366